Literature DB >> 16825400

Comparison of Acinetobacter baumannii isolates from the United Kingdom and the United States that were associated with repatriated casualties of the Iraq conflict.

Jane F Turton1, Mary E Kaufmann, Martin J Gill, Rachel Pike, Paul T Scott, Joel Fishbain, David Craft, Gregory Deye, Scott Riddell, Luther E Lindler, Tyrone L Pitt.   

Abstract

Acinetobacter isolates associated with casualties from the Iraq conflict from the United States were compared with those from the United Kingdom by pulsed-field gel electrophoresis and integron analysis. Representatives of the main outbreak strain associated with casualties from both countries were indistinguishable in DNA profile. Two further outbreak strains were common to both sets of isolates.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16825400      PMCID： PMC1489513          DOI： 10.1128/JCM.00547-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

2.  BSAC standardized disc susceptibility testing method (version 4).

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2005-05-23       Impact factor: 5.790

Review 3.  Multiresistant acinetobacter in the UK: how big a threat?

Authors:  J Coelho; N Woodford; J Turton; D M Livermore
Journal:  J Hosp Infect       Date:  2004-11       Impact factor: 3.926

4.  Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq.

Authors:  Anna Jones; Dilys Morgan; Amanda Walsh; Jane Turton; David Livermore; Tyrone Pitt; Andy Green; Martin Gill; Deborah Mortiboy
Journal:  Lancet Infect Dis       Date:  2006-06       Impact factor: 25.071

5.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

6.  Acinetobacter.

Authors:  J J Rahal; C Urban
Journal:  Semin Respir Crit Care Med       Date:  2000       Impact factor: 3.119

7.  Infections due to Acinetobacter baumannii in the ICU.

Authors:  Jean Chastre
Journal:  Semin Respir Crit Care Med       Date:  2003-02       Impact factor: 3.119

8.  Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom.

Authors:  Jane F Turton; Mary E Kaufmann; Judith Glover; Juliana M Coelho; Marina Warner; Rachel Pike; Tyrone L Pitt
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

9.  Infectious diseases during wartime.

Authors:  Michael J Zapor; Kimberly A Moran
Journal:  Curr Opin Infect Dis       Date:  2005-10       Impact factor: 4.915

10.  Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-11-19       Impact factor: 17.586
View more
  36 in total

Review 1.  Infection in conflict wounded.

Authors:  W G P Eardley; K V Brown; T J Bonner; A D Green; J C Clasper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-01-27       Impact factor: 6.237

2.  Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.

Authors:  N C Gordon; K Png; D W Wareham
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

3.  Use of the accessory genome for characterization and typing of Acinetobacter baumannii.

Authors:  Jane F Turton; Buket Baddal; Claire Perry
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

Review 4.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

5.  Genome sequences of four divergent multidrug-resistant Acinetobacter baumannii strains isolated from patients with sepsis or osteomyelitis.

Authors:  Daniel V Zurawski; Mitchell G Thompson; Christin N McQueary; Malcolm N Matalka; Jason W Sahl; David W Craft; David A Rasko
Journal:  J Bacteriol       Date:  2012-03       Impact factor: 3.490

6.  Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.

Authors:  Jonathan A Otter; Eleonora Dyakova; Karen N Bisnauthsing; Antonio Querol-Rubiera; Amita Patel; Chioma Ahanonu; Olga Tosas Auguet; Jonathan D Edgeworth; Simon D Goldenberg
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

7.  Rapid determination of quinolone resistance in Acinetobacter spp.

Authors:  Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Jodi M Thomson; Mark D Adams; Karrie Goglin; Philip N Rather; Thuy-Trang D Pennella; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Lawrence B Blyn; David J Ecker; Robert A Bonomo
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 9.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas.

Authors:  Samuel A Shelburne; Kavindra V Singh; A Clinton White; Laura Byrne; Alexis Carmer; Celest Austin; Edward Graviss; Charles Stager; Barbara E Murray; Robert L Atmar
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.